Search | Page 38 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. 2012 Scientific Symposium

    ... young investigators to learn about the key areas of current research and to explore the most promising directions for the future.  ... Excellent basic science and major new advances in clinical care were presented by the world's experts. The lively and close ...

    Page last updated 01/12/2015 - 12:20pm.

  2. Health Care Team Players: Meet the Nurse

    ... of health care professionals. Some RN’s are involved in research.  Bone marrow failure patients may have advance practice ... team. APRN’s have pursued additional education and clinical practice requirements. They may be nurse practitioners (NPs) or ...

    Page last updated 05/29/2015 - 9:46am.

  3. MDS and MDS/MPN: Past, Present, and Future 2014 American Society of Hematology (ASH) Satellite Symposium Summary for Patients and Families

    ... of this symposium was to bring together leaders in disease research and clinical practice to review the contributions of cytogentics and molecular ...

    Page last updated 03/13/2015 - 5:00pm.

  4. Transplantation: What Do Your Patients Hear?

    ... their own. Once way to accommodate this need is to maximize clinical opinions as a substitute the dearth of research data about transplants and BMFD. Encouraging second opinions for such ...

    Page last updated 04/23/2015 - 11:07am.

  5. Nursing Education Modules on MDS Disease Management and Patient Education

    ... MDS – azacitidine , decitabine , allo-HSCT, clinical trials MDS treatment goals – individualized therapy, minimal ... common elements of the concept of QOL Review of various research instruments for measuring QOL Domains included in QOL measurements ...

    Page last updated 04/27/2015 - 2:44pm.

  6. Ramon V. Tiu, MD

    ... Therapy in Aplastic Anemia Original Research Center:  Cleveland Clinic Lerner Research ... single nucleotide polymorphism arrays, especially in their clinical application in myeloid malignancies like myelodysplastic ...

    Grant Recipient last updated 10/30/2012 - 6:28pm.

  7. Hideki Makishima, MD, PhD

    ... clonal expansion Original Research Center:  Cleveland Clinic Foundation ... hemoglobinuria (PNH) is a blood disease with chronic clinical course. PNH has been considered a genetically simple disease caused by ...

    Grant Recipient last updated 07/07/2014 - 11:46am.

  8. Gregory Abel, MD

    ... Myelodysplastic Syndrome Original Research Center:  Dana-Farber Cancer Institute ... Moving forward, they plan to validate the measure for use in clinical trials by administering it to a much larger group of patients from ...

    Grant Recipient last updated 09/28/2012 - 3:14pm.

  9. Strategic Plan 2014-2106

    ... Professional Education Patient Education Research Public Awareness and Information Patient and Family Support ... to accelerate time-to-diagnosis and treatment, to improve clinical outcomes, and to enhance the care experience. Goal 2: Fully ...

    Page last updated 09/12/2014 - 10:56am.

  10. Resistance to Hypomethylating Agents in the Treatment of MDS

    ... to 60% to 80% overall response rates for MDS patients in clinical trials. But that still means about 25% or more patients are ... hypothesis in a prospective manner will help support this research and may help us direct therapeutic choices for our future patients. ...

    Interview last updated 06/17/2014 - 9:15am.